Recurrent Aseptic Meningitis Complicating Intravenous Immunoglobulin Therapy for CIDP
Neurol 42:1636-1637, Vera-Ramirez,M.,et al, 1992
The Risk of Stroke in Patients with Acute Myocardial Infarction after Thrombolytic and Antithrombotic Treatment
NEJM 327:1-6, Maggioni,A.P.,et al, 1992
Safety & Efficacy of Intravenous Tissue Plasminogen Activator & Heparin in Acute Middle Cerebral Artery Stroke
Stroke 23:646-652, vonKummer,R.&Hacke,W., 1992
Intracranial Hemorrhage After Coronoary Thrombolysis with Tissue Plsminogen Activator
Am J Med 92:384-390, Kase,C.S.,et al, 1992
Recombinant Tissue Plasminogen Activator in Acute Thrombotic and Embolic Stroke
Ann Neurol 32:78-86, delZoppo,G.J.,et al, 1992
Urgent Therapy for Stroke Part II, Pilot Study of Tissue Plasminogen Activator Administered 91-180 Minutes from Onset
Stroke 23:641-645, Haley,E.C.,et al, 1992
Urgent Therapy for Stroke Part I, Pilot Study of Tissue Plasminogen Activator Administered within 90 Minutes
Stroke 23:632-640, Brott,T.G.,et al, 1992
Myopathy in Severe Asthma
Am Rev Respir Dis 146:517-519, Douglass,J.A.,et al, 1992
Early Computed Tomographic Findings for Thrombolytic Therapy in Patients with Acute Brain Embolism
Stroke 23:20-23, Okada,Y.,et al, 1992
Olanzapine in the Treatment of Dopaminomimetic Psychosis in Patients with Parkinson's Disease
Neurol 47:1085-1087, Wolters,W.Ch.,et al, 1992
Drug-Induced Movement Disorders:An Overview
In Movement Dis in Neurol & Neuropsych, Blackwell Sci Publ, Boston, 2:21., Miller,L.G.&Jankovic,J., 1992
Neuroleptic-Induced Catatonia as a Stage in the Progression Toward NMS
J Am Acad Child Adolesc Psychiatry 31:1161-1164, Woodbury,M.M.&Woodbury,M.A., 1992
The Use of Sedative Agents in Critically Ill Patients
Drugs 43:507-515, Burns,A.M.,et al, 1992
Extrapyramidal side Effects of Antiemetics Presenting as Psychiatric Illness
Gen Hosp Psychiatry 14:192-195, Rodgers,C., 1992
Tissue Plasminogen Activator Plus Glutamate Antagonist Improves Outcome after Embolic Stroke
Arch Neurol 48:1235-1238, Zivin,J.A.&Mazzarella,V., 1991
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
CT patterns of Intracranial Hemorrhage Complicating Thrombolytic Therapy for Acute Myocardial Infarction
Radiology 181:555-559, Uglietta,J.P.,et al, 1991
Cholesterol-Lowering Agent Myopathy (CLAM)
Neurol 41:1159-1160, London,S.F.,et al, 1991
Aggravation of Myasthenia Gravis by Erythromycin
J Pediatr 119:155-156, Absher,J.R.&Bale,J.F., 1991
Colchicine-Induced Myopathy and Neuropathy
Neurol 41:943, Younger,D.S.,et al, 1991
Thiamine Deficiency in Patients with Congestive Heart Failure Receiving Long-Term Furosemide Therapy:A Pilot Study
Am J Med 91:151-155, Seligmann,H.,et al, 1991
CNS Side Effects of Nonsteroidal Anti-Inflammatory Drugs, Aseptic Meningitis, Psychosis & Cognitive Dysf
Arch Int Med 151:1309-1313, Hoppmann,R.A.,et al, 1991
Acute Psychoses Associated with the Use of Ciprofloxacin & Trimethoprim-Sulfamethoxazole
Am J Med 90:528-529, McCue,J.D.&Zandt,J.R., 1991
A Wernicke's Encephalopathy-Like Neurotoxicity Induced by Erbulozole
Neurol 41:762-763, DeKloppel,N.,et al, 1991
Akinetic Mutism after Baclofen
Ann Int Med 115:499-500, Parmar,M.S., 1991
Hormone Replacement Therapy Induced Chorea
BJM 302:762, Steiger,M.J.&Quinn,N.P., 1991
Cerebral Air Embolism Treated by Pressure and Hyperbaric Oxygen
Neurol 41:314-315, Catron,P.W.,et al, 1991
Diagnostic Evaluation of Syncope
Am J Med 90:91-106, Kapoor,W., 1991
Next-Day Memory Impairment with Triazolam Use
Lancet 337:827-831, Bixler,E.O.,et al, 1991
Aseptic Meningitis Associated with High Dose Intravenous Immunoglobulin Therapy
JNNP 54:275-276, Watson,J.D.G.,et al, 1991
The Evaluation and Treatment of Seizures
NEJM 323:1468-1474, Scheuer,M.L.&Pedley,T.A., 1990
Syncope and Presyncope Associated with Probable Adverse Drug Reactions
Arch Int Med 150:2309-2312, Hanlon,J.T.,et al, 1990
Aggravation of Myasthenia Gravis by Erythromycin
Ann Neurol 28:577-579, May,E.F.&Calvert,P.C., 1990
"Stelazine"versus"Selegiline"-A Hazard in Prescription Writing, Letter
NEJM 323:1776, Kurth,M.C.,et al, 1990
Persistent Dystonia Associated with Buspirone
Neurol 40:1904, Boylan,K., 1990
A Double-Blind, Controlled Trial of Intravenous Immunoglobulin in Patients with Chronic Fatigue Syndrome
Am J Med 89:561-568, 551-5531990., Lloyd,A.,et al, 1990
A Controlled Trial of Intravenous Immunoglobulin G in Chronic Fatigue Syndrome
Am J Med 89:554-560, 551-5531990., Peterson,P.K.,et al, 1990
Diagnostic Utility of Flumazenil in Coma with Suspected Poisoning:A Double Blind, Randomized Controlled Study
BMJ 301:1308-1311, Hojer,J.,et al, 1990
Ergotamine Headache Mistaken for Temporal Arteritis
Ann Neurol 28:396, Winterkorn,J.M.S.,et al, 1990
Nontraumatic Coma, Glasgow Coma Score and Coma Etiology as Predictors of 2-Week Outcome
Arch Neurol 47:1181-11884, Sacco,R.L.,et al, 1990
A Functional Psychosis Precipitated by Quinidine
Med J Aust 153:47-49, Johnson,A.G., 1990
The Diagnosis and Treatment of Cerebral Myocotic Aneurysms
Ann Neurol 27:238-246, Brust,J.C.M.,et al, 1990
Drug-Induced Meningitis
Neurol 40:163-164, Gordon,M.F.,et al, 1990
Clinical Uses of Intravenous Immunoglobulins
Ann Int Med 112:278-292, Berkman,S.A.,et al, 1990
Muscle Cramps
Arch Int Med 150:511-518, McGee,S.R., 1990
Intracranial Hemorrhage After Use of Tissue Plasminogen Activator for Coronary Thrombilysis
Ann Int Med 112:17-21, Kase,C.S.,et al, 1990
Digoxin Toxicity Presenting with Visual Disturbance and Trigeminal Neuralgia
Neurol 40:1469-1470, Johnson,L.N., 1990
Intravenous Immune Globulin and Acute Aseptic Meningitis
NEJM 323:614-615, Van-Daele,M.C.,et al, 1990
Eosinophilic Fasciitis Associated with the Eosinophilia-Myalgia Syndrome
Am J Med 88:542-546, Jaffe,I.,et al, 1990
Eosinophilia-Myalgia Syndrome Associated with Exposure to Tryptophan From a Single Manufacturer
JAMA 264:213-217, Slutsker,L.,et al, 1990